Ticker

Training Business Accelerates with Hundreds of Physicians from over 50 Countries at our Flagship Cancún Global Summit. ISSCA 125 Global Summit is scheduled to combine five ISSCA certification tracks and an international scientific conference under one program, as part of the Company's physician-education activities conducted through Global Stem Cells Group.

ISSCA's most comprehensive credential to date integrates regenerative medicine, biotechnology, longevity medicine, and artificial intelligence - a durable, multi-year physician-relationship asset. New multi-component fellowship is designed to combine regenerative medicine, biotechnology, longevity medicine, clinical implementation, and physician-controlled clinical-intelligence tools offered through ISSCA AI™.

Physician-controlled lab-to-plan workflow, ISSCA protocol ingestion, licensed technology partnership, and clinic-facing SaaS and membership design - with the physician remaining the decision-maker MIAMI, FL / ACCESS Newswire / September 14, 2026 / Regenerative Medical Technology Group, Inc. (the "Company" or "RMTG") (OTCID:RMTG), operating through its wholly owned subsidiary Global Stem Cells Group, today issued an…

Colombia is the third Latin American market in which Cellgenic has recently announced local commercial arrangements. Activity remains subject to applicable Colombian law and the terms of local contracts.

Cellgenic is expanding local representation and commercial support in Brazil, one of Latin America's larger healthcare and aesthetic-medicine markets. ISSCA continues to hold physician-education events in São Paulo.